Shares of Biogen Inc (NASDAQ: BIIB) are down about 8.0% on Wednesday after the U.S. Medicare programme refused to cover for its Alzheimer’s drug, Aduhelm, unless the patient is enrolled in an approved...
Shares of Biogen Inc (NASDAQ: BIIB) are down about 8.0% on Wednesday after the U.S. Medicare programme refused to cover for its Alzheimer’s drug, Aduhelm, unless the patient is enrolled in an approved...